202 studies found for:
Open Studies | "Hyperlipidemias"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia
|
||||
| 2 | Available |
Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia
|
||||
| 3 | Unknown † |
Telemedicine Based Management of Hyperlipidemia
|
||||
| 4 | Unknown † |
Jiangzhuo Prescription ,Fenofibrate and Placebo in the Treatment of Hyperlipidemia (Syndrome of Phlegm Obstruction)Clinical Study (JZF)
|
||||
| 5 | Recruiting |
Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients
|
||||
| 6 | Recruiting |
Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy
|
||||
| 7 | Recruiting |
The Effects of a Mediterranean Diet in Pediatric Hyperlipidemia
|
||||
| 8 | Recruiting |
Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
|
||||
| 9 | Unknown † |
The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients’ Lipid Profiles
|
||||
| 10 | Unknown † |
Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume
|
||||
| 11 | Unknown † |
The Effect of Providing Free Samples of Generic Cardiovascular Medications to Physicians
|
||||
| 12 | Unknown † |
Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)
|
||||
| 13 | Recruiting |
Cardiovascular Intervention Improvement Telemedicine Study
|
||||
| 14 | Recruiting |
Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome
|
||||
| 15 | Not yet recruiting |
Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients
|
||||
| 16 | Recruiting |
Endothelial Hyperpolarization in Humans
|
||||
| 17 | Unknown † |
A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction
|
||||
| 18 | Unknown † |
Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C
|
||||
| 19 | Unknown † |
Niaspan in Diabetic Nephropathy
|
||||
| 20 | Not yet recruiting |
Nutraceuticals to Improve Lipid Profile in European Countries
|
† Indicates status has not been verified in more than two years
